Present Your Research at RDD 2026
The Poster Session at RDD 2026 presents research on all aspects of pulmonary and nasal delivery. Posters will be presented in Phoenix, Arizona, as a traditional poster augmented by a ten-minute recorded presentation for on-demand viewing.
The abstract submission deadline is January 23, 2026.
Accepted abstracts will be published in the Conference Proceedings available to all conference delegates, and those from graduate students will be automatically eligible for the VCU RDD Peter R. Byron Graduate Student Award. The award covers registration fee, travel expenses and accommodation up to a maximum of $2000.
Posters on the Podium will showcase editor-selected posters during a series of ten-minute presentations in the main auditorium followed by a fast-paced Q&A session. All poster abstracts and on-demand presentations will be featured in online Knowledge Spaces.
Registration fees will be waived for graduate students (no more than 2 per advisor) with an accepted poster abstract if their academic advisor is registered to attend at the discounted academic rate of $995. It is expected that the graduate student (not their academic or industrial advisor) will present the poster in Arizona. By waiving the registration fee, we hope to encourage young scientists to attend RDD, where they'll receive expert feedback on their work, hear the latest from opinion leaders, and network with peers, collaborators and future employers.
When and Where?
Posters will be continuously accessible to delegates from 10:00 AM until 7:00 PM on Monday, May 11, and from 8:30 AM to 7:00 PM on Tuesday, May 12, in the Kierland Ballroom. The Poster and Exhibition Session will be the only RDD event during the following times:
- Monday, May 11, 11:30 AM–2:30 PM and 5:00–7:00 PM
- Tuesday, May 12, 11:30 AM–2:30 PM and 5:00–7:00 PM
Posters, exhibit tables, lunch and refreshment breaks will share an expansive space to maximize interactivity.
Submit your Poster Abstract
Poster Presentations
Sana Hosseini
From Droplets To Particles: Excipients Shaping Spray‑dried Intranasal PowdersBenjamin Thorne
Simulating In Vitro Aerosolization Performance: A Tool To Support Valve Selection For Suspension pMDI ProductsCroda
Veronica Freitas Blanco
Improving Intranasal Delivery Of Epinephrine And Naloxone Hydrochloride Using Excipients In A 3D Nasal Tissue ModelNavid Monshi Tousi
In Silico Evaluation Of Nasal Spray Plume Angle And Ovality On Regional Nasal DepositionHosein Sadafi
Using Rapid Deposition Analysis And rAPSD Variability To Support In Silico Bioequivalence AssessmentHealthy Airways
Loy Britto
Evaluation Of Albuterol Sulfate Formulations With Low GWP Propellants Using A Non-PAFS Coated MDI CanInformiX Pharma
Parmesh Gajjar
Determining Material Composition Of Fines-only Formulations Through X-ray Computed TomographyJohannes Gutenberg-Universität Mainz
Moritz Fleischhauer
Single Jet Impaction As An Alternative Mechanism For Soft Mist GenerationKeith Ung
Design Of Spray Dried GLP-1 Exenatide Microparticles For Pulmonary Delivery: A Room-temperature Stable Formulation Of An Oxidation Sensitive PeptideKeith Ung
Recording And Analysis Of Healthy Subjects Breathing Maneuvers With An Adheresp Breath-actuated NebulizerMichael Shultz
Excipient Effects On Spray-dried Antibody Stability: A Comparative StudyVaishnavi Kapileshwari
Understanding Morphological Aspects Of API And Excipient Particles In DPI FormulationsNitto BioPharma
Chun Yang
Innovative Lipid Nanoparticle Platforms For mRNA Delivery To The LungDavid Lewis
Defining “immediate” Actuation In Suspension pMDIs: Acoustic, Gravimetric And Delivered Dose Characterisation Of Shake–fire TimingScientific Consultant
Stephen Stein
A Simple Calculation To Provide Insight Into Impact Of Propellant On Spray PatternYannick Baschung
Adapting Standard Nasal Spray Testing Methodologies For Live BSL-2 Viral Products: An In-use Case Study With A SARS-CoV-2 Nasal VaccineThe University of Alabama at Birmingham
Teri Ross
Particle Level Assessment Of Morphology And Composition As A Function Of Aerosol Particle Size Using Optical Photothermal Infrared Microscopy: Comparison Of Fluticasone/salmeterol/lactose In Advair Diskus And Wixela InhubMark Nagel
Can A Mixing Inlet Interposed Between A Pressurized Metered Dose Inhaler-spacer Combination And Cascade Impactor Enable Effective Performance Testing At Widely Different Inhalation Flow Rates?BS
U.S. Food & Drug Administration
Bora Sul
Computational Modeling Of Actuation Timing Effects On Regional Lung Drug Delivery From Pressurized Metered-dose InhalersAC
University of Bristol
Anna Catton
Rapid Stability Modelling as a Predictor for Long-term Standard Stability TestingUniversity of Bristol
Sorrel Haughton
Effect Of Viscosity And Surface Tension On The Spray Characteristics And Nasal Cavity Deposition Of Liquid Nasal Sprays In A VP7 DeviceHR
University of Hertfordshire
Hessam Rasooli Nia
Nasal Delivery Of Liquid Medicines: Effect Of Viscosity And Polymer Structure On Delivery Performance.University of Michigan
Grace Xia
A Distribution-based Metric For Quantifying Dispersibility In Dry Powder InhalersGZ
University of Michigan
Guizhi (Julian) Zhu
Airway Delivery Of CircRNA Using Pulmonary-surfactant-coated Lipid Nanoparticles For Cystic Fibrosis Gene TherapyFrancesca Buttini
Engineering Budesonide Microparticles For Stable Suspension In pMDIsUniversity of Sydney
Zhengqi Xu
Combination Of A Newly Developed Modified Next Generation Impactor (mNGI) And Franz Cell Method For In Vitro Dissolution Characterization Of Inhalation Powders: Development And ValidationUniversity of Sydney
Zhengqi Xu
Modified Next Generation Impactor (mNGI) And Franz Cell For Characterization Of The In Vitro Dissolution Performances Between Innovator And Generic Dry Powder InhalersFC
Federica Carnamucio
Inhalable Liposomal Combination Therapy For The Treatment Of Osteosarcoma Lung MetastasesWoolcock Institute of Medical Research
Patrick He
Bridging Deposition And Permeation: Evaluation Of Intranasal Dry Powder Antiemetic Formulations
Poster Abstract and Submission Instructions
We strive to publish impactful, scientifically accurate high-quality abstracts. Those with a high chance of acceptance:
- Describe recent, relevant experiments, innovations and insights
- Include data or outline groundbreaking concepts or approaches
- Support claims and conclusions with data or references, especially those making comparisons to competing commercial products
- Use scientific language understandable by researchers in the field
- Have not been presented at other conferences
Three- to five-page poster abstracts should be submitted in Microsoft Word. Use double-spaced Arial 12-point font. Please follow instructions in the Poster Abstract Instructions and share these with any colleagues or third-party vendors who are assisting you.
The Publication Process
- You must submit your poster abstract using the web portal before January 23, 2026.
- A reviewer will evaluate your submitted poster abstract and communicate a decision to the primary author before March 6, 2026. Reviewers may accept, reject or request modifications. Corrections must be made within 5 days.
- You must obtain and send us permission from the original publisher to include previously published materials in your poster abstract. Permission should be sent to info@rddonline.com. Most publishers have their own process to request permission but if not, please use our Copyright Permission Request Form.
- Your reviewer will accept or reject your final abstract before March 30, 2026.
- You must E-mail a signed Copyright Transfer Form (as a PDF) to info@rddonline.com by March 30, 2026 so we can publish your work. Authors retain the right to use the content of their articles as they see fit, including extending their work into manuscripts submitted to journals. The Copyright Transfer Form gives RDD ownership of the final typeset abstract. We grant complimentary permission to use tables, figures and verbatim quotations in journal articles in exchange for acknowledgement that RDD was the original publisher.
- The publisher will typeset your abstract and email you PDF proofs to review and correct. You should return the proofs by email within 48 hours of receipt. Please only make typographical corrections at this stage.
- Questions about the publication process should be sent to Richard Dalby, University of Maryland.
Questions?
For further information, contact Richard Dalby.
